Fr. 70.00

Limits of Patentability - Plant Sciences, Stem Cells and Nucleic Acids

English · Paperback / Softback

Shipping usually within 6 to 7 weeks

Description

Read more

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer's privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids.

List of contents

Preface.- Andreas Hübel: The Boundaries of Limits - Plant Biosciences.- Ulrich Storz: The Limits of Patentability - Stem Cells.- Aloys Hüttermann: The LImits of Patentability - Genes and Nucleic Acids.- About the Authors.

About the author

Aloys Hüttermann erhielt 1998 den Steinhofer-Preis der Albert-Ludwigs Universität Freiburg für seine Diplomarbeit in Chemie. 2001 promovierte er an der Ruhr-Universität Bochum mit einer Arbeit auf dem Gebiet der organischen Synthese. Seit 2006 ist Dr. Hüttermann als Patentanwalt in eigener Kanzlei tätig.

Summary

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer’s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids.

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.